Complement C5-deficient mice are protected from seizures in experimental cerebral malaria

Epilepsia

Volumn 55, Issue 12, 2014, Pages e139-e142

  Buckingham, Susan C ^a   Ramos, Theresa N ^b   Barnum, Scott R ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Plasmodium berghei ANKA; Terminal complement pathway

Indexed keywords

COMPLEMENT COMPONENT C5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL CEREBRAL MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; SEIZURE; ANIMAL; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; MALARIA; PATHOGENICITY; SEIZURES;

ANIMALS; COMPLEMENT C5; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM BERGHEI; SEIZURES;

EID: 84919960331     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12858     Document Type: Article

References (11)

1. White NJ, Pukrittayakamee S, Hien TT, et al. Malaria. Lancet 2014; 383: 723-735.
2. Mishra SK, Newton CR,. Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol 2009; 5: 189-198.
3. Ramos TN, Darley MM, Hu X, et al. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. J Immunol 2011; 186: 6657-6660.
4. Ramos TN, Darley MM, Weckbach S, et al. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. J BiolChem 2012; 287: 24734-24738.
5. Patel SN, Berghout J, Lovegrove FE, et al. C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med 2008; 205: 1133-1143.
6. Marchi N, Granata T, Janigro D,. Inflammatory pathways of seizure disorders. Trends Neurosci 2014; 37: 55-65.
7. Kim H, Erdman LK, Lu Z, et al. Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria. Infect Immun 2014; 82: 371-379.
8. Darley MM, Ramos TN, Wetsel RA, et al. Deletion of carbo-zxypeptidase N delays onset of experimental cerebral malaria. Parasite Immunol 2012; 34: 444-447.
9. Xiong ZQ, Qian W, Suzuki K, et al. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 2003; 23: 955-960.
10. Casarsa C, De Luigi A, Pausa M, et al. Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain. Eur J Immunol 2003; 33: 1260-1270.
11. Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006; 355: 1233-1243.